Pharmacy News

Officials have confirmed an outbreak of bird flu in Suffolk, but stress the risk to the public is low

The drug has hit survival and disease progression targets in Phase III trials

Children with cystic fibrosis as young as six months with certain mutations can now access the treatment

The main reason for not sharing DNA for drug research is the fear it could be used without knowledge for corporate gain

NHS funding was backed for four medicines

NHS patients will be able to access the treatment via clinical trials

The project will utilise Healx' AI-based drug discovery platform

"We are clearly in the worst state we’ve ever been in as we enter the true winter season", says College president Dr Katherine Henderson.

The French drugmaker is spending around $2.5 billion on the deal

The drug demonstrates “remarkable efficacy”, says AZ’ José Baselga

Policymakers must identify fragmented systems and promote better data sharing, study authours say

Janssen's JNJ-4528 and BMS/bluebird bio's liso-cel show 100% response rates

Genetic regulation is set to become a fifth primary focus for the Japanese drugmaker, on top of its already existing business lines.

The online retail giant's honed data abilities will help Novartis produce more personalised therapies.

The treatment could offer a new option for patients unable to reach viral supression

This year's competition welcomed a fantastic spread of companies as well as a higher number of entrants

Flying the flag for clinical research for over 20 years, this competition continues to grow and develop year after year.

If approved, the drug will be the only non-binder treatment for the control of serum phosphorus in patients with CKD on dialysis.

The fish oil-derived therapy is already approved in the US for patients with severe hypertriglyceridaemia.

The system gives users “greater flexibility” to customise the company's established CRM.